Pharmaloz manufacturing accelerates expansion, improves pricing, boosts profitability and secures new contracts

Pharmaloz wins two new contracts in january that are anticipated to significantly increase lozenge revenues and profitability company in late-stage discussions with two additional large global brands which, if consummated, could more than triple run-rate of revenues before year-end 2024
PRPH Ratings Summary
PRPH Quant Ranking